share_log

康惠制药(603139.SH):新建生产基地通过药品GMP符合性检查

Shaanxi Kanghui Pharmaceutical (603139.SH): New production base passes pharmaceutical GMP compliance inspection.

Gelonghui Finance ·  Aug 13 05:23

Shaanxi Kanghui Pharmaceutical (603139. SH) announced on August 13th that the new production base at No. 36 Yan Zhi Road, Qindu District, Xianyang City has passed the drug production quality management standard conformity check (referred to as "drug GMP Conformity Inspection") and obtained the Drug Production License issued by the Shaanxi Provincial Drug Administration. The new production base of the company has passed the drug GMP conformity inspection and obtained the "Drug Production License", indicating that the relevant production lines of the new production base of the company meet the GMP requirements, which is conducive to the company's continued stable production capacity and to meet market demand. Due to the industry characteristics of pharmaceutical products, the production and sales of drugs are affected by market environment, industry policies, supply and demand relations and other factors, and have certain uncertainties.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment